From relief to risks: a comprehensive review of medical cannabis

Nidhi Lokhande; Aditya Mokal; Namita Deshmukh; Avinash Borkar; Suvarna Patil

doi:10.18203/2394-6040.ijcmph20251740

Authors

Nidhi Lokhande BKL Walawalkar Rural Medical College, Ratnagiri, Maharashtra, India
Aditya Mokal BKL Walawalkar Rural Medical College, Ratnagiri, Maharashtra, India
Namita Deshmukh Department of Community Medicine, Dr Rajendra Gode Medical College, Amravati, Maharashtra, India
Avinash Borkar Department of Community Medicine, Dr Rajendra Gode Medical College, Amravati, Maharashtra, India
Suvarna Patil Department of General Medicine, BKL Walawalkar Rural Medical College, Ratnagiri, Maharashtra, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20251740

Keywords:

Clinical research, Health risks, Medical cannabis, Regulation and legalization, Therapeutic benefits

Abstract

Cannabis has been used for medicinal purposes for thousands of years, with a resurgence in modern medical applications sparking significant research and regulatory discussions. This review explores the medical benefits, risks, mechanisms of action, and legal considerations of cannabis use. Cannabis-based treatments have shown efficacy in managing multiple conditions, including chronic pain, multiple sclerosis, psychiatric disorders, chemotherapy-induced nausea, epilepsy, and neurodegenerative diseases. Despite its therapeutic potential, cannabis use carries short- and long-term risks, including cognitive impairment, cardiovascular issues, dependency, and adverse mental health effects. The variability in cannabis products, dosing, and regulation raises concerns regarding safety and quality control. Additionally, ethical dilemmas exist in prescribing unstandardized cannabis-based therapies. Legalization trends across various regions continue to shape the accessibility and acceptance of medical cannabis, though significant research gaps remain. Future studies are required to further validate its efficacy, optimize dosing strategies, and mitigate potential health risks. This review provides a comprehensive overview of current evidence, highlighting both the promise and challenges associated with medical cannabis.

Metrics

Metrics Loading ...

References

Pratt M, Stevens A, Thuku M, Butler C, Skidmore B, Wieland LS, et al. Benefits and harms of medical cannabis: a scoping review of systematic reviews. Syst Rev. 2019;8(1):320. DOI: https://doi.org/10.1186/s13643-019-1243-x

Rup J, Freeman TP, Perlman C, Hammond D. Cannabis and mental health: Prevalence of use and modes of cannabis administration by mental health status. Addict Behav. 2021;121:106991. DOI: https://doi.org/10.1016/j.addbeh.2021.106991

Atakan Z. Cannabis, a complex plant: different compounds and different effects on individuals. Ther Adv Psychopharmacol. 2012;2(6):241-54. DOI: https://doi.org/10.1177/2045125312457586

Baker D, Pryce G, Giovannoni G, Thompson AJ. The therapeutic potential of cannabis. Lancet Neurol. 2003;2(5):291-8. DOI: https://doi.org/10.1016/S1474-4422(03)00381-8

Bridgeman MB, Abazia DT. Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting. P T. 2017;42(3):180-8.

Karki P, Rangaswamy M. A review of historical context and current research on cannabis use in India. Indian J Psychol Med. 2023;45(2):105-16. DOI: https://doi.org/10.1177/02537176221109272

Hill KP, Gold MS, Nemeroff CB, McDonald W, Grzenda A, Widge AS, et al. Risks and benefits of cannabis and cannabinoids in psychiatry. Am J Psychiatry. 2022;179(2):98-109. DOI: https://doi.org/10.1176/appi.ajp.2021.21030320

Lu HC, Mackie K. Review of the Endocannabinoid System. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(6):607-15. DOI: https://doi.org/10.1016/j.bpsc.2020.07.016

Webb CW, Webb SM. Therapeutic benefits of cannabis: a patient survey. Hawaii J Med Public Health. 2014;73(4):109-11.

National Academies of Sciences, Medicine, Medicine Division, Board on Population Health, Public Health Practice, Committee on the Health Effects of Marijuana, An Evidence Review, Research Agenda. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Available at: https://www.ncbi.nlm.nih.gov. Accessed on 21 January 2025.

Leinen ZJ, Mohan R, Premadasa LS, Acharya A, Mohan M, Byrareddy SN. Therapeutic potential of cannabis: a comprehensive review of current and future applications. Biomed. 2023;11(10):2630. DOI: https://doi.org/10.3390/biomedicines11102630

Malfitano AM, Proto MC, Bifulco M. Cannabinoids in the management of spasticity associated with multiple sclerosis. Neuropsychiatr Dis Treat. 2008;4(5):847-53. DOI: https://doi.org/10.2147/NDT.S3208

Scherma M, Muntoni AL, Riedel G, Fratta W, Fadda P. Cannabinoids and their therapeutic applications in mental disorders. Dialogues Clin Neurosci. 2020;22(3):271-9. DOI: https://doi.org/10.31887/DCNS.2020.22.3/pfadda

Bodine M, Kemp AK. Medical cannabis uses in oncology. 2024. Available at: https://www.ncbi.nlm.nih. Accessed on 21 November 2024.

Bennici A, Mannucci C, Calapai F, Cardia L, Ammendolia I, Gangemi S, et al. Safety of medical cannabis in neuropathic chronic pain management. Molecules. 2021;26(20):6257. DOI: https://doi.org/10.3390/molecules26206257

Desai P, Mbachi C, Vohra I, Salazar M, Mathew M, Randhawa T, et al. Association between cannabis use and healthcare utilization in patients with irritable bowel syndrome: a retrospective cohort study. Cureus. 2020;12(5):8008. DOI: https://doi.org/10.7759/cureus.8008

Patel RS, Kamil S, Shah MR, Bhimanadham NN, Imran S. Pros and Cons of Marijuana in Treatment of Parkinson's Disease. Cureus. 2019;3;11(6):e4813. DOI: https://doi.org/10.7759/cureus.4813

Zaheer S, Kumar D, Khan MT, Giyanwani PR, Kiran F. Epilepsy and cannabis: a literature review. Cureus. 2018;10(9):3278. DOI: https://doi.org/10.7759/cureus.3278

Kim SH, Yang JW, Kim KH, Kim JU, Yook TH. A Review on Studies of Marijuana for Alzheimer's Disease - Focusing on CBD, THC. J Pharmacopuncture. 2019;22(4):225-230. DOI: https://doi.org/10.3831/KPI.2019.22.030

Lopez MJ, Nataneli N. Cannabis use for glaucoma and associated pain. Available at: https://www.ncbi.nlm.nih.gov. Accessed on 22 December 2024.

Woolridge E, Barton S, Samuel J, Osorio J, Dougherty A, Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage. 2005;29(4):358-67. DOI: https://doi.org/10.1016/j.jpainsymman.2004.07.011

McMahon I, Harris-Lane LM, Donnan J, Bishop L, Harris N. Emerging adult perceptions of higher-risk cannabis consumption behaviours. Harm Red J. 2023;20(1):127. DOI: https://doi.org/10.1186/s12954-023-00860-4

Sachs J, McGlade E, Yurgelun-Todd D. Safety and Toxicology of Cannabinoids. Neurotherapeutics. 2015;12(4):735-46. DOI: https://doi.org/10.1007/s13311-015-0380-8

Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219-27. DOI: https://doi.org/10.1056/NEJMra1402309

Begum J. Medical marijuana benefits and side effects. WebMD Editorial Contributors. 20224. Avaialble at: https://www.webmd.com. Accessed on 21 November 2024.

Hoch E, Volkow ND, Friemel CM. Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits. Eur Arch Psychiatry Clin Neurosci. 2024;3:56. DOI: https://doi.org/10.1007/s00406-024-01880-2

MacCallum CA, Lo LA, Boivin M. "Is medical cannabis safe for my patients?" A practical review of cannabis safety considerations. Eur J Intern Med. 2021;89:10-8. DOI: https://doi.org/10.1016/j.ejim.2021.05.002

Subramaniam VN, Menezes AR, DeSchutter A, Lavie CJ. The Cardiovascular Effects of Marijuana: Are the Potential Adverse Effects Worth the High. Mo Med. 2019;116(2):146-53.

Archie SR, Cucullo L. Harmful effects of smoking cannabis: a cerebrovascular and neurological perspective. Front Pharmacol. 2019;10:1481. DOI: https://doi.org/10.3389/fphar.2019.01481

Jacobus J, Tapert SF. Effects of cannabis on the adolescent brain. Curr Pharm Des. 2014;20(13):2186-93. DOI: https://doi.org/10.2174/13816128113199990426

Sagy I, Peleg-Sagy T, Barski L, Zeller L, Jotkowitz A. Ethical issues in medical cannabis use. Eur J Intern Med. 2018;49:20-2. DOI: https://doi.org/10.1016/j.ejim.2018.01.016

Arnold JC. A primer on medicinal cannabis safety and potential adverse effects. Aust J Gen Pract. 2021;50(6):345-50. DOI: https://doi.org/10.31128/AJGP-02-21-5845

Fischer B, Robinson T, Bullen C, Curran V, Jutras-Aswad D, Medina-Mora ME, et al. Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update. Int J Drug Policy. 2022;99:103381. DOI: https://doi.org/10.1016/j.drugpo.2021.103381

Belackova V. “The Good, the Bad, and the Ugly Weed”: How Consumers in Four Different Policy Settings Define the Quality of Illicit Cannabis. Contemporary Drug Problems. 2020;47(1):43-62. DOI: https://doi.org/10.1177/0091450919897658

Glickman A, Sisti D. Prescribing medical cannabis: ethical considerations for primary care providers. J Med Ethics. 2020;46(4):227-30. DOI: https://doi.org/10.1136/medethics-2019-105759

Cornella FA. Medical Marijuana and Professional Ethics. Mo Med. 2020;117(6):532.